Nataraj Dasgupta serves as the Vice President of Analytics at RxDataScience Inc., where he plays a pivotal role in shaping the future of healthcare through innovative AI and machine learning solutions. As a founding member of RxDataScience, Nataraj has been instrumental in the company's evolution,...
Nataraj Dasgupta serves as the Vice President of Analytics at RxDataScience Inc., where he plays a pivotal role in shaping the future of healthcare through innovative AI and machine learning solutions. As a founding member of RxDataScience, Nataraj has been instrumental in the company's evolution, which culminated in a successful acquisition by Syneos Health in 2021. His expertise lies in leveraging TB-scale real-world evidence (RWE), claims, and prescription data to develop cutting-edge healthcare analytics solutions that drive better patient outcomes and optimize clinical decision-making.
Currently, Nataraj is focused on the ideation and development of Generative AI products, harnessing both commercial models like GPT and Gemini, as well as open-source solutions. His work emphasizes model grounding and domain adaptation, ensuring that AI systems are finely tuned to meet the specific needs of the healthcare industry. By integrating advanced analytics with robust risk management strategies, he is able to deliver low-latency insights that empower healthcare providers and stakeholders to make informed decisions swiftly.
Nataraj's multifaceted skill set encompasses big data analytics, trading systems, and financial risk management, allowing him to navigate the complexities of the healthcare landscape effectively. His dual presence in New York City and London positions him at the forefront of global health-tech innovation, where he continues to explore the intersection of technology and healthcare, driving RxDataScience's mission to transform patient care through data-driven insights.
